Business Strategy

A report on a pair of surveys from West reveals interesting findings about patient engagement, prevention, wellness, and quality of care.

: In some cases of healthcare fraud, it’s easy to spot red flags. But in large healthcare organizations, or on the payer end, fraud and waste can be more difficult to detect through layers and layers of data.

New healthcare fraud schemes are emerging. Here are a few of the most noteworthy.

While these types of programs have been in place for several years, it can be difficult to gauge who is using them and how, and whether they are achieving their intended goal.

Fluctuations in drug pricing and medication shortages are among the reasons for rising drug prices. Learn how you can protect your hospital’s bottom line.

A study from West reveals interesting findings about patient engagement, prevention, wellness, and quality of care.

Managing the care for members with cancer is unlike managing care for other chronic diseases. Here’s five ways to better care for cancer patients.

A new survey on genetic testing has surprisingly results on consumer acceptance and impact for healthcare executives.

A survey unveiled at the HealthCare Executive Group’s Annual Forum divulges surprising findings about healthcare technology and innovation.

We asked successful healthcare industry leaders to share their top tips for young executives. Here’s what they said.

A new survey from consumer health companies has revealing findings about American health and well-being.

Genetics and genomics are starting to have an impact on cardiovascular care. Here’s what payers should consider when deciding whether to cover a gene expression test.

A Kaiser Permanente study found that a new way to test for HPV has the potential to increase efficiency and decrease waste.

Here are four ways CMS’ final rule related to the 340B Drug Pricing Program could affect the healthcare industry.

The Trump Administration issued two rules rolling back the federal requirement that employers include birth control coverage in their group health plans. Here’s what you need to know.

Widespread adoption of population-focused nursing practice will likely take place over the next five to 10 years. Here’s how to stay ahead of the curve.

New public opinion survey about opioid use from Prime Therapeutics has surprising results.

The CVS Health-Aetna potential merger will have healthcare executives rethinking traditional industry competitors. Here’s why.

Healthcare executives identify how the industry could be affected if the Aetna-CVS merger goes through.

Is interoperability in healthcare a dream, or will payers, providers, and technology vendors finally come together to make data more available to one another?

New data from CMS show that ACOs succeed at producing quality gains and cost savings, but at least one effort begs to differ.

The success of any value-based care model depends on achieving a strong relationship with members. Here’s three ways how.

Payers’ biggest concerns for 2018, health insurance exchange participation plans, and how offerings could change.

A new study has unbelievable findings about treating Medicare patients with diabetes.

A Robert Wood Johnson Foundation expert analyzes the Altarum Institute’s study on healthcare growth findings.